Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Neurogastroenterol Motil. 2014 Oct 19;26(12):1771–1782. doi: 10.1111/nmo.12459

Table 1.

Pharmacological profile of HM01

Determination Values
hGHS-R1a binding, Ki 1.42 ± 0.36 nM
hGHS-R1a calcium signaling, EC50 1.25 ± 0.15 nM
Bioavailability (rat) 70.6 ± 26.9%
Half-life in plasma (rat) 4.3** ± 1.0 h
CNS permeability, Kp brain/plasma (rat) 0.73 ± 0.14 ( at 2 h)
0.80 ± 0.23 (at 4 h)
0.67* (at 8 h)
*

: n = 1

**

: Half-life calculated after HM01 oral administration

Kp: ratio of brain and plasma concentrations